NEWS

VirginiaCancerRx in the News!

John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...

Targeted Nanoparticle Delivery of Paclitaxel

Virginia Tech scientists have developed a cancer drug that increases the effectiveness of a common chemotherapy treatment and dramatically reduces devastating side effects, such as hair loss, nausea, and nerve pain. The new drug uses gold nanoparticles created by the...

Potential drug therapy for radiation exposure

Potential new treatments for radiation exposure: The investigators exploited an optimized, cell-based,high throughput screening assay to interrogate a small
molecule library comprising 3437 known pharmacologically
active compounds for mitigation against IR-induced...